| Symbol | GRMLW |
|---|---|
| Name | KLOTHO NEUROSCIENCES, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 1300 SOUTH BOULEVARD,SUITE D, CHARLOTTE, North Carolina, 28203, United States |
| Telephone | +1 833 931-6330 |
| Fax | — |
| — | |
| Website | https://www.klothoneuro.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001907223 |
| Description | Klotho Neurosciences, Inc. (NASDAQ: KLTO), a biopharmaceutical company specializing in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders. The Company obtained exclusive worldwide rights to platform technologies and knowhow to develop cutting edge protein, gene and cell therapies to treat age-related pathologies such as ALS, Alzheimers and Parkinsons Disease, multiple sclerosis and rare neurodegenerative diseases. The companys current portfolio consists of its proprietary gene therapy program using DNA and RNA as therapeutics and diagnostics. Other assets include clinical-stage programs involving antibody biologics targeting cancer and autoimmune diseases, and drug delivery via a needle-free dry powder jet autoinjector called Nanoject. Additional info from NASDAQ: |
Greenland Mines Arrives at Skaergaard, Commences Drilling as 2026 Field Season Moves into Full Operation
Read more(99% Neutral) KLOTHO NEUROSCIENCES, INC. (GRMLW) Announces Regulatory Update
Read moreGreenland Mines Departs for Skaergaard – Expanded 2026 Program Targeting Next Phase of Development
Read moreBiotech Division of Greenland Mines Announces Issuance of Patent in Canada for the Klotho Gene Therapy Platform Technology for Alzheimer’s and Aging
Read moreThis Greenland Rare Earth and Precious Metals Company Just Put Up a Takeover Defense, and It Says Something About How It Views Its Own Value
Read moreSawyer Jason David 🟢 acquired 240.0K shares of Greenland Mines Ltd (GRML) at $0.23 Transaction Date: Jul 22, 2026 | Filing ID: 080657
Read more(99% Neutral) KLOTHO NEUROSCIENCES, INC. (GRML) Announces Business Combination
Read moreGreenland Mines Announces Limited-Duration Stockholder Rights Plan Intended to Protect Shareholder Value
Read moreNew Form 8-A12B - Greenland Mines Ltd <b>Filed:</b> 2026-07-23 <b>AccNo:</b> 0001213900-26-080648 <b>Size:</b> 297 KB
Read more(99% Neutral) KLOTHO NEUROSCIENCES, INC. (GRMLW) Announces Regulatory Update
Read more